July 31, 2013 at 11:50 AM EDT
Wall Street Fundamentals Releases New In-Depth Stock Reports on INSY, MNTA, OREX and TEAR
The biotech industry continued to outpace the broader markets in July as a number of companies reported major news that have sent shares soaring. The iShares NASDAQ Biotechnology Index ETF (IBB) has gained over 13 percent in the past month, more than triple the 3.9 percent gain posted by the Dow Jones over the same period. Recent programs introduced by the FDA designed to speed up the approval process and improve communication channels with biotech companies have provided a major confidence boost for the industry The FDA has approved a total of 14 new drugs in 2013, new drug approvals reached a 15-year high in 2012 (39).
Insys Therapeutics Inc. (NASDAQ: INSY) shares traded in the range of $15.43 to $17.57 Tuesday before settling to close at $16.05, a decrease of 7.06 percent. The stock appears to be facing some resistance at the $17.28 and $19.75 levels. Shares of Insys Therapeutics have gained approximately 16.0 percent in the past month.
More information on Insys Therapeutics and access to the free equity report can be found at:
Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA) shares traded in the range of $16.91 to $17.69 Tuesday before settling to close at $17.23, a decrease of 1.49 percent. The stock appears to have some support at the $16.74, $15.97 and $15.53 levels. Shares of Momenta Pharmaceuticals have gained approximately 14.0 percent year-to-date.
More information on Momenta Pharmaceuticals and access to the free equity report can be found at:
Orexigen Therapeutics, Inc. (NASDAQ: OREX) shares traded in the range of $7.47 to $7.70 Tuesday before settling to close at $7.60, a decrease of 0.39 percent. The stock appears to have support at $7.35, $6.83 and $6.64. Shares of Orexigen Therapeutics have gained over 30.0 percent in the past month.
More information on Orexigen Therapeutics and access to the free equity report can be found at:
TearLab Corp. (NASDAQ: TEAR) shares traded in the range of $14.52 to $14.91 Tuesday before settling to close at $14.55, a decrease of 1.22 percent. The stock appears to be facing some resistance at $19.98 with some support at the $13.78 and $12.65. Shares of TearLab have gained approximately 37.0 percent in the past month.
More information on TearLab and access to the free equity report can be found at:
Wall Street Fundamentals offers our members a full range of investor services including in-depth equity reports on your favorite companies and timely market updates featuring the hottest stocks trending in the marketplace.
Activate your always free membership by signing up at www.WallStreetFundamentals.com today.
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Wall Street Fundamentals has no financial relationship with any company whose stock is mentioned in this release.
Wall Street Fundamentals
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here